{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:02:02Z","timestamp":1772578922614,"version":"3.50.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1S","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.juro.2012.11.016","type":"journal-article","created":{"date-parts":[[2012,12,9]],"date-time":"2012-12-09T00:18:35Z","timestamp":1355012315000},"source":"Crossref","is-referenced-by-count":32,"title":["Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer"],"prefix":"10.1097","volume":"189","author":[{"given":"Matthew R.","family":"Smith","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital Cancer Center, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald A.","family":"Morton","sequence":"additional","affiliation":[{"name":"GTx Incorporated, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Gary","family":"Barnette","sequence":"additional","affiliation":[{"name":"GTx Incorporated, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Sieber","sequence":"additional","affiliation":[{"name":"Urologic Associates of Lancaster, Lancaster, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Bruce","family":"Malkowicz","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"GTx Incorporated, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Hancock","sequence":"additional","affiliation":[{"name":"GTx Incorporated, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell S.","family":"Steiner","sequence":"additional","affiliation":[{"name":"GTx Incorporated, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.11.016_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2012.11.016_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.11.016_bib3","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2012.11.016_bib4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.juro.2012.11.016_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.016_bib6","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.016_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S8756-3282(99)00117-9","article-title":"The structural basis of bone fragility in men","volume":"25","author":"Seeman","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.juro.2012.11.016_bib9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMcp0707217","article-title":"Clinical practice","volume":"358","author":"Ebeling","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.016_bib10","first-page":"1212","article-title":"Assessment of vertebral fractures in osteoporosis research","volume":"24","author":"Genant","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.juro.2012.11.016_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jc.87.2.599","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.016_bib12","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.016_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MOU.0b013e32832a082c","article-title":"Complications of androgen deprivation therapy in prostate cancer","volume":"19","author":"Schwandt","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2012.11.016_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00003495-199754010-00014","article-title":"Toremifene","volume":"54","author":"Wiseman","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.juro.2012.11.016_bib15","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2004.22.14_suppl.4597","article-title":"Toremifene citrate versus placebo for treatment of bone loss and other complications of androgen deprivation therapy in patients with prostate cancer","volume":"22","author":"Steiner","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.016_bib16","series-title":"SAS\/STAT 9.1 User's Guide","year":"2004"},{"key":"10.1016\/j.juro.2012.11.016_bib17","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2012.11.016_bib18","series-title":"Statistical Methods in Cancer Research Volume 1- the Analysis of Case-Control Studies","author":"Breslow","year":"1980"},{"key":"10.1016\/j.juro.2012.11.016_bib19","first-page":"129","article-title":"The analysis of several 2 x 2 contingency tables","volume":"58","author":"Zelen","year":"1971","journal-title":"Biometrika"},{"key":"10.1016\/j.juro.2012.11.016_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2012.11.016_bib21","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1210\/jc.2003-032058","article-title":"Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2012.11.016_bib22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/01.ju.0000063820.94994.95","article-title":"Randomized controlled trial of zoledronic acid to prevent bone loss in men undergoing androgen deprivation therapy for nonmetastatic prostate cancer","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.11.016_bib23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-146-6-200703200-00006","article-title":"Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2012.11.016_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.11.016_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s001980050218","article-title":"Vertebral fractures predict subsequent fractures","volume":"10","author":"Melton","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.juro.2012.11.016_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00198-003-1405-4","article-title":"The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population","volume":"14","author":"Naves","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.juro.2012.11.016_bib27","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2012.11.016_bib28","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.juro.2009.01.047","article-title":"Metabolic complications of androgen deprivation therapy for prostate cancer","volume":"181","author":"Saylor","year":"2009","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471205481X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471205481X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.11.016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T22:57:56Z","timestamp":1651186676000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.11.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":27,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1016\/j.juro.2012.11.016"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.11.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969664.793469648","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}